Pregnancy Hypertension Linked to Heart Disease Later in Life: Study

Preeclampsia and other pregnancy hypertension disorders are one of the leading causes of maternal and fetal death worldwide, and researchers warn that the conditions may also pose later heart risks for the mother.

Women who experience high blood pressure during pregnancy may face a significant risk of developing heart disease within a few years after giving birth, according to the findings of a new research.

In a study published this month in the medical journal JAMA Network Open, British researchers warn that genetic hypertension conditions among pregnant women appear to be linked with an increased risk of coronary artery disease and ischemic stroke.

Researchers from the National Heart and Lung Institute at the Imperial College London conducted a genome-wide genetic association study following more than 250,000 people in 2022. Pregnancy hypertensive conditions were identified as any condition during pregnancy related to high blood pressure, including gestational hypertension, and preeclampsia/eclampsia.

Preeclampsia is a pregnancy complication marked by abnormally high blood pressure. It can lead to kidney damage, and organ damage, and in serious cases that aren’t treated quickly, it can lead to death for the mother or the infant. The condition is a leading cause of pregnancy-related death worldwide, largely because hospitals are unprepared to treat the condition.

Prior research has linked preeclampsia to an increased risk of heart disease and stroke in the child later in life. However, this new study suggests that mothers may also face a future risk.

Hypertensive disorders in general during pregnancy are a major cause of maternal and fetal death worldwide and are linked to the future risk of cardiovascular disease for both the mother and child.

Pregnancy Hypertension Heart Disease Risks

In this new study, researchers identified more than 122,000 cases of coronary artery disease during the study period, more than 34,000 cases of ischemic stroke, nearly 48,000 cases of heart failure, and 60,000 cases of atrial fibrillation.

Genetically predicted hypertensive disorders in pregnancy were linked with a higher risk of coronary artery disease and ischemic stroke. There was no link between pregnancy hypertension and heart failure or atrial fibrillation risk.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Part of the risk may be attributed to cardiometabolic factors, such as obesity, type 2 diabetes, and high cholesterol. These conditions can often lead to the onset of other conditions, like high blood pressure. But those conditions don’t account for the entire risk posed to pregnant women with hypertension.

“The findings of this study provide genetic evidence supporting an association between hypertensive disorders in pregnancy and higher risk of coronary artery disease and stroke, which is only partially mediated by cardiometabolic factors,” researchers wrote. “This supports the classification of HDPs as risk factors for cardiovascular disease.”

The researchers concluded that the results highlight the need to consider hypertensive disorders during pregnancy as important risk factors for heart disease. Pregnant patients should be screened and monitored for risk factors and symptoms to offer early treatment and help prevent long-term risks.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.